Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announces today that members of its senior leadership team will present datasets on the world’s first and only approved ...
It scares the bejesus out of me because he is really, I would say, one of the big leaders in an anti-science philosophy that we see in this country — which is really concerning, deeply concerning,” ...
Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines, has presented positive clinical safety and immunogenicity data from a clinical phase 1 study of ...